Study and analysis of cervical pap smears in our hospital


  • Suvidha Saurabh Department of Obstetrics and Gynaecology, ESIC HCH, Bihta, Patna, Bihar, India
  • Sanjita Department of Obstetrics and Gynaecology, ESIC HCH, Bihta, Patna, Bihar, India
  • Ismat Khanam Department of Obstetrics and Gynaecology, ESIC HCH, Bihta, Patna, Bihar, India



Carcinoma, Cervix, Pap smear, Ayer’s spatula, Bethesda, Pre malignant, Screening


Background: Cervical cancer is one of the major causes of mortality among women worldwide. It has taken fourth place among malignancies that affect women, the first leading is breast cancer. In developing countries including India, it is the leading cause of morbidity and mortality. It is readily preventable and can be diagnosed at the pre invasive stage with adequate and repetitive cytological screening and Papanicolaou smears.

Methods: This observational study was aimed to screen the patients attending gynae OPD of ESIMCH, Bihta. The main purpose was to study the incidence of premalignant and malignant lesions in population in and around ESICMCH, Bihta. A total of 100 patients attending gynaecology OPD of ESIC, Bihta were screened during a period of one year from October 2022 to September 2023. Pap smears are taken from women visiting gynaecological OPD between ages of 25 to 70 with different gynaecological complaints using Ayer’s spatula. Smears were reported according to Bethesda system 2001.

Results: A total of 200 pap smears were examined. There were 68 patients with NILM, and 67 patients with inflammatory smear. ASCUS was found in 12 patients, LSIL in 10 patients, HSIL in 7 and squamous cell carcinoma in 1 patient. This study concluded that a simple pap smear test could be offered to vast populations for diagnosing premalignant conditions of the survey this has and will in future continue to aid us with the early diagnosis of survival cancer.

Conclusions: PAP smear is useful in diagnosing malignant and premalignant lesions of the cervix. In developing countries such as India this screening method is cheap and can be widely used. It can be used by trainers and para medical staffs.


Samar G, Mustard. Pattern and factors affected Pap smear test in Nablus, a retrospective study. Middle East J Family Med. 2004;4:1-11.

National Cancer registry programme. Annual report 2021. Available at: NCRPAreports.aspx. Acceded on 15 June, 2023.

Khan MS, Raja FY. PAP smear screening for pre cancerous conditions of the cervical cancers. Pak J Med Res. 2005;44(3):111-3.

Monica Idestrom, Ian M, Agneta AE. Women's experience of coping with a positive Pap smear: a register-based study of women with two consecutive pap smears reported as CIN1. Acta Obstet Gynecol Scand. 2003;82(8):756-61.

A practical manual on visual screening of cervical neoplasia. IARC Press. 2003. IARC Technical Publication number. 2003;41.

International Network for Cancer Treatment and Research. A Practical Manual on Visual Screening for Cervical Neoplasia. 2003. Available at: Acceded on 15 June, 2023.

Hande C, Mehmetoglu, Ganime S. Paps smear screening in the primary healthcare setting: A study from Turkey. N Am J Med Sci. 2010;2:1-28.

Pradhan B, Pradhan SB, Mittal VP. Correlation of Pap smear findings with clinical findings and cervical biopsy. Kathmandu Univ Med. 2007;5(4):461-7.

Nayar R, Wilbur DC. The Pap test and Bethesda 2014. Cancer Cytopathlog. 2015;123(5):271-81.

Bamanikar SA, Baravkar DS, Chandanwale SS, Dapkekar P. Study of Cervical Pap Smears in a Tertiary Hospital. Indian Medical Gazette. 2014:250-254.

Mandakini MP, Amrish NP, Jigna MM. Cervical pap smear study and its utility in cancer screening, to specify the strategy for cervical cancer control. National J Community Med. 2011;2(1):49-51.

Garg P, Mishra S, Divedi P. Cervical Pap smear study and its utility in cancer screening in patients attending out-patient department in a tertiary care hospital. Int J Reprod Contracept Obstet Gynecol. 2021;10(9):3521-4.

Verma A, Verma S, Vashist S, Attri S, Singhal A. A study on cervical cancer screening in symptomatic women using Pap smear in a tertiary care hospital in rural areas of Himachal Pradesh, India. Middle East Fertility Society J. 2017;22(1):39-42.






Original Research Articles